20148 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals; Wall or coating material Inorganic compounds
METHOD FOR DRYING FECAL MICROBIOTA MULTILAYER DRIPPING PILLS
#2COMPOSITIONS AND METHODS FOR AUGMENTING BIOHYBRID CHEMICAL SENSOR PERFORMANCE THROUGH NANO-NEUROMODULATION
#3PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME
#4CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING INDIGO NATURALIS OR ITS MAIN ACTIVE INGREDIENT AND PREPARATION METHOD AND USE THEREOF
#5Hollow Hydroxyapatite Microparticles for Controlled Release of Osteoprotegerin and Their Use in Orthodontic and Bone Regenerative Therapies
#6PHARMACEUTICALLY EFFECTIVE COMPOSITION FOR CONTROLLED DRUG DELIVERY
#7METAL OXIDE ENCAPSULATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME
#8THREE-DIMENSIONAL PRINTED STRUCTURAL SILOXANES HAVING CONTROLLED DRUG RELEASE
#9MULTILAYERED PHARMACEUTICALLY ACTIVE COMPOUND-RELEASING MICROPARTICLES IN A LIQUID DOSAGE FORM
#10METHYLPHENIDATE MODIFIED RELEASE FORMULATIONS
#11STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
#12MODIFIED RELEASE FORMULATIONS OF IBUDILAST
#13INHALABLE COMPOSITIONS OF CDK9 INHIBITORS
#14PREPARATION OF POLYPEPTIDE FORMULATIONS USING VAPOR PHASE DEPOSITION
#15STABLE FORMULATIONS WITH REDUCED SOLID STATE REACTIONS
#16COMPOSITIONS AND METHODS OF USE FOR STABILIZING AND DELIVERY OF ATOMIC LAYER DEPOSITION COATING OF AGENT-CONTAINING LIPID-EMULSION FORMULATIONS
#17PREPARATION OF ABUSE-DETERRENT PHARMACEUTICAL FORMULATIONS USING VAPOR PHASE DEPOSITION
#18Method for preparing SAMe microcapsules
#19Phloroglucinol Formulations And Methods Of Use
#20COMPOSITIONS COMPRISING ENCAPSULATED TRETINOIN
#21PROBIOTICS ENCAPSULATED WITH CALCIUM CARBONATE AND METHOD FOR PREPARING SAME
#222,4-Dinitrophenol Formulations and Methods Using Same
#23PARTICLE COMPRISING A VIRUS
#24NEW COMPOSITION COMPRISING IMMUNOMODULATORY DRUG
#25Intestine-Targeted Drug Delivery Compositions and Preparation Methods Thereof
#26NEW COATING SYSTEM (II)
#27ORAL FORMULATION OF A PYRIDINONE DERIVATE AND USE THEREOF IN PROPHYLAXIS AND/OR TREATMENT OF INTESTINAL FIBROSIS
#28NEW INJECTABLE COMBINATION FORMULATION
#29COATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME
#30PHARMACEUTICAL FORMULATION
#31Method of using binary coating agents in powder coating to achieve enhanced properties of the coated powder and its blends having cohesive powders
#32PREPARATION OF PHARMACEUTICAL COMPOSITIONS USING SUPERCYCLE VAPOR PHASE DEPOSITION OF METAL OXIDES
#33ROBOTIC MICROCAPSULE ASSEMBLIES WITH EMERGENT MOBILITY FOR TARGETED TREATMENT AND DRUG DELIVERY
#34MICROMOTORS AND NANOMOTORS FOR GASTROINTESTINAL DIAGNOSIS AND TREATMENT APPLICATIONS
#35Obizidine Fumarate Enteric-coated Pellets, and preparation and use thereof
#36POWDER COMPOSITION
#37METAL OXIDE ENCAPSULATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME
#38NEW FORMULATIONS COMPRISING AZACITIDINE
#39NEW FORMULATIONS COMPRISING BIOLOGIC ACTIVE DRUGS
#40NEW PROCESS
#41COMPOSITIONS AND METHODS FOR REDUCING ADVERSE EFFECTS OF STORAGE, TRANSPORT AND ADMINISTRATION OF ANTIGEN-CONTAINING FORMULATIONS
#42LAYERED PARTICLES AND PROCESSES THEREOF
#43METHOD FOR COATING PHARMACEUTICAL SUBSTRATES
#44COMPOSITIONS AND METHODS FOR TREATING DEPRESSION AND ANXIETY
#45CURCUMIN NANOPARTICLE COMPLEX HAVING MODIFIED PARTICLE SURFACE AND METHOD FOR PREPARING SAME
#46METHOD FOR PRODUCING SILICA MICROCAPSULE
#47COATED BETA HYDROXYBUTYRIC ACID CRYSTAL AND METHODS FOR PRODUCING THE SAME
#48CHITOSAN-Fe COATING-BASED SYNBIOTIC MICROCAPSULE WITH GASTRIC ACID RESISTANCE AND INTESTINAL TARGETED RELEASE AND PREPARATION METHOD THEREOF
#49Pharmaceutical formulation
#50FORTIFIED MICRONUTRIENT SALT FORMULATIONS
#51MULTIPARTICULATE DOSAGE FORMS COMPRISING DEUTETRABENAZINE
#52DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME
#53SULFUR FUNCTIONALIZED MONOLITHS AND PARTICLES DERIVED FROM THE SAME AS NITRIC OXIDE CARRIERS FOR PHARMACEUTICAL AND COSMETIC APPLICATIONS
#54OZONE-BASED LOW TEMPERATURE SILICON OXIDE COATING FOR PHARMACEUTICAL APPLICATIONS
#55STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
#56MICROENCAPSULATION PROCESS AND PRODUCT
#57Opioid receptor modulator dosage formulations
#58SOLID DISPERSIONS AND PARTICLES AND METHODS FOR CONTROLLED-RELEASE OF LIPID-SOLUBLE OR DISPESIBLE ACTIVES
#59POLYMERSOMES, COLLOIDOSOMES, LIPOSOMES, AND OTHER SPECIES ASSOCIATED WITH FLUIDIC DROPLETS
#60USE OF LOW IRON OXIDE IRON-DOPED TITANIUM DIOXIDE NANOPARTICLES IN THE TREATMENT OF TUMORS AND OTHER DISEASES
#61NOVEL FINE PARTICLE COATING (DRUG-CONTAINING HOLLOW PARTICLE AND METHOD FOR MANUFACTURING SAME)
#62MICROCAPSULE HAVING CORE-SHELL STRUCTURE, AND PRODUCTION METHOD FOR SAME
#63INJECTABLE OIL-BASED PHARMACEUTICAL COMPOSITION
#64Taste Masked And Rapidly Disintegrating Ultra Thin Iron Orodispersible Film And A Process Thereof
#65LOW TEMPERATURE SILICON OXIDE COATING FOR PHARMACEUTICAL APPLICATIONS
#66Coated API Particles
#67Method for coating pharmaceutical substrates
#68DOSAGE FORM FOR USE IN TREATING OR PREVENTING OF A DISEASE
#69DELIVERY OF BIOLOGICS VIA MINERAL CRYSTALS FOR REGENERATIVE MEDICINE APPLICATIONS
#70NEW PROCESS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS
#71Timed-elution masking particles and oral pharmaceutical composition containing the same
#72PANCREATIN MICROCAPSULES
#732,4-dinitrophenol formulations and methods using same
#74APPARATUS
#75VAPOR PHASE COATINGS FOR PHARMACEUTICAL SOLUBILITY CONTROL
#76MODIFIED RELEASE FORMULATION OF A PYRIMIDINYLAMINO-PYRAZOLE COMPOUND, AND METHODS OF TREATMENT
#77NESTED CELL ENCAPSULATION
#78MICROCAPSULE
#79Metal oxide encapsulated drug compositions and methods of preparing the same
#80BIODEGRADABLE EXTENDED RELEASE MICROSPHERE-HYDROGEL OCULAR DRUG DELIVERY SYSTEM AND METHOD
#81Sustained release solid dosage forms for modulating the colonic microbiome
#82Amantadine compositions, preparations thereof, and methods of use
#83Low temperature process for preparing silicon oxide coated pharmaceuticals
#84Opioid receptor modulator dosage formulations
#85Particulate coated hydrogel microparticles
#86Opioid receptor modulator dosage formulations
#87Opioid receptor modulator dosage formulations
#88NEW COMPOSITION COMPRISING AMORPHOUS NANOPOROUS SILICA PARTICLES
#89Coated drug compositions and methods of preparing the same
#90Stabilized microcapsules, method of their preparation and uses thereof
#91Stabilized microcapsules, method of their preparation and uses thereof
#92STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
#93Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
#94Stimulus activated cork-shell capsules
#95Mineral coated microparticles for co-delivery of anti-inflammatory molecules with nucleic acids to improve gene delivery outcomes
#96Extended release compositions comprising trihexyphenidyl
#97CHITOSAN GELS (A) CONTAINING METAL NANOPARTICLES OF COPPER, SILVER AND ANTIBIOTICS (CIPROFLOXACIN, CEFOTAXIME, GENTAMICIN AND CLOXACILLIN)
#98Core stabilized microcapsules, method of their preparation and uses thereof
#99Host-guest metal organic framework systems
#100SELF-EMULSIFYING SOLID ORAL DOSAGE FORMS OF ALLERGEN AND THEIR PREPARATION THEREOF
#101Opioid receptor modulator dosage formulations
#102Opioid receptor modulator dosage formulations
#103PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL
#104MICROENCAPSULATED MODIFIED POLYNUCLEOTIDE COMPOSITIONS AND METHODS
#105Pharmaceutical composition of Tamsulosin and Dutasteride
#106POWDER COATING COMPOSITIONS FOR COATING PHARMACEUTICAL PELLETS
#107PROCESS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS
#108TASTE-MASKED PHARMACEUTICAL COMPOSITIONS WITH GASTROSOLUBLE PORE-FORMERS
#109MAGNETIC LIQUID PARTICLES
#110Encapsulated antimicrobials and related methods of treatment
#111STRUCTURED NANOCOATINGS FOR THE STABILIZATION OF PLURIPOTENT STEM CELL MEDIA COMPONENTS
#112PHARMACEUTICALLY EFFECTIVE COMPOSITION FOR CONTROLLED DRUG DELIVERY
#113Encapsulated antimicrobials and related methods of treatment
#114METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACNE
#115ENCAPSULATING AGENT WITH IMPROVED PROPERTIES ADAPTED FOR CELL ENCAPSULATION
#116Sustained release solid dosage forms for modulating the colonic microbiome
#117PHARMACEUTICAL ABUSE DETERRENT COMPOSITION CONSTRUCTED IN MORE THAN ONE STRENGTHS
#118Opioid receptor modulator dosage formulations
#119Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
#120Apparatus for coating particles
#121METHODS FOR THE TREATMENT OF ROSACEA
#122Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
#123METHOD FOR PREPARING PARTICLES COMPRISING METAL OXIDE COATING AND PARTICLES WITH METAL OXIDE COATING
#1242,4-dinitrophenol formulations and methods using same
#125Fine particle coating (drug-containing hollow particle and method for manufacturing same)
#126METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACNE
#127Encapsulation Methods and Compositions
#128THREE-DIMENSIONAL PRINTED STRUCTURAL SILOXANES HAVING CONTROLLED DRUG RELEASE
#129PHARMACEUTICAL FORMULATION
#130PARTICLES FOR THE TREATMENT OF CANCER IN COMBINATION WITH RADIOTHERAPY
#131Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
#132CORE-SHELL NANOPARTICLES
#133COATED PARTICLES
#134POLYMERSOMES, COLLOIDOSOMES, LIPOSOMES, AND OTHER SPECIES ASSOCIATED WITH FLUIDIC DROPLETS
#135Method for coating pharmaceutical substrates
#136Gel formulation for treating diabetic foot ulcer infections
#137MRI-DETECTABLE MULTILAYER MICROCAPSULES FOR ULTRASOUND-TRIGGERED DELIVERY OF PHARMACOLOGICALLY ACTIVE AGENTS
#138Microencapsulation process and product
#139Mineral coated microparticles for co-delivery of anti-inflammatory molecules with nucleic acids to improve gene delivery outcomes
#140Mineral coated microparticles for gene delivery in chronic wound therapy
#141Molecular system for cancer biology
#142Amantadine compositions and preparations thereof
#143Method to generate microcapsules with hexahydrotriazine (HT)-containing shells
#144Layered particles and processes thereof
#145Magnetic nanoparticle delivery system for pain therapy
#146BASIC CORE MATERIAL ENCAPSULATED IN AN INORGANIC SHELL SUITABLE FOR USE IN BIOLOGICAL CARRIER MATERIALS
#147UNIFORM FILMS FOR RAPID DISSOLVE DOSAGE FORM INCORPORATING TASTE-MASKING COMPOSITIONS
#148Tamper resistant oral opioid agonist formulations
#149Micromotors and nanomotors for gastrointestinal diagnosis and treatment applications
#150NANOMATERIAL AND METHOD OF PRODUCTION OF A NANOMATERIAL FOR MEDICAL APPLICATIONS, SUCH AS MRI OR SERS
#151Methods and compositions for the treatment of acne
#152Delayed release cysteamine bead formulation, and methods of making and using same
#153Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
#154Compositions and methods for reducing overdose
#155Particle containing at least a volatile substance and process for its preparation
#156Methods of using amantadine compositions
#157Metal oxide encapsulated drug compositions and methods of preparing the same
#158TIME RELEASE OF FAT-SOLUBLE ACTIVES
#159FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEREOF
#160Biomolecule preservation
#161Tamper resistant pharmaceutical formulations
#162Nitric oxide containing composite
#163Solid simethicone particles and dosage form thereof
#164Compositions and methods for preparing polymeric films loaded with uniformly distributed drug particles
#165Composition comprising porous silica particles carrying a cell fate modulating factor
#166OVERDOSE PROTECTION AND ABUSE DETERRENT IMMEDIATE RELEASE DRUG FORMULATION
#167ENCAPSULATING AGENT WITH IMPROVED PROPERTIES ADAPTED FOR CELL ENCAPSULATION
#168Enteric coated oral pharmaceutical preparation comprising dimethyl fumarate
#169Methods and compositions for the treatment of acne
#170METHOD OF ACNE TREATMENT BY CONCOMITANT TOPICAL ADMINISTRATION OF BENZOYL PEROXIDE AND TRETINOIN
#171METHOD OF ACNE TREATMENT BY CONCOMITANT TOPICAL ADMINISTRATION OF BENZOYL PEROXIDE AND TRETINOIN
#172COMPOSITIONS COMPRISING ENCAPSULATED TRETINOIN
#173Method for producing colloidosome microcapsules
#174Multiphasic particles fabricated by wettability engendered templated self-assembly (WETS) methods
#175Core stabilized microcapsules, method of their preparation and uses thereof
#176ANTIMICROBIAL COMPOSITIONS COMPRISING BIOGLASS
#177Microcapsules and compositions providing controlled release of actives
#178Pharmaceutically effective composition for controlled drug delivery
#179Method to generate microcapsules with hexahydrotriazine (HT)-containing shells
#180Polyphosphate glass microspheres, methods of making and uses thereof
#181POLYMERSOMES, LIPOSOMES, AND OTHER SPECIES ASSOCIATED WITH FLUIDIC DROPLETS
#182ORAL LIQUID COMPOSITIONS OF GUANFACINE
#183PHOTO-RESPONSIVE MACRO- AND MICRO- LIQUID MARBLES
#184Core stabilized microcapsules, method of their preparation and uses thereof
#185COMPOSITIONS AND METHODS FOR OBTAINING AN IMPROVED LUNG FUNCTION
#186Method of synthesis of silica vesicles and use thereof
#187GAMMA-HYDROXYBUTYRIC ACID GRANULES
#188EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF MIXED AMPHETAMINES
#189PHARMACEUTICAL COMPOSITIONS COMPRISING EVEROLIMUS
#190METHODS FOR THE TREATMENT OF ROSACEA
#191Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
#192POWDER COATING COMPOSITIONS FOR COATING PHARMACEUTICAL PELLETS
#193Microcapsule
#194CORE-SHELL NANOPARTICLES
#195Hollow nanoparticles with hybrid double layers
#196Control release of fat soluble antioxidants from an oral formulation and method
#197Composition for the treatment of neuropathies and/or neuropathic pain
#198Tamper resistant oral opioid agonist formulations
#199Ceramic encapsulation by use of one or more specialized silanes to template oil in an oil in water emulsion
#200Protocells for Plasmid and RNP Delivery in the Treatment of Cancer and Other Disease States
#201Co-encapsulation of live cells with oxygen-generating particles
#202PHARMACEUTICAL FORMULATION HAVING REVERSE THERMAL GELATION PROPERTIES FOR LOCAL DELIVERY OF NANOPARTICLES
#203Formulations of histone deacetylase inhibitor and uses thereof
#204A DRUG-CONTAINING MICRO PARTICLE
#205Bioactive Wound Dressing and Teeth Coating Based on Morphogenetically Active Amorphous Calcium Polyphosphate
#206Pharmaceutical formulations of xanthine or xanthine derivatives, and their use
#207DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#208DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#209DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#210Opioid receptor modulator dosage formulations
#211UNIFORM FILMS FOR RAPID DISSOLVE DOSAGE FORM INCORPORATING TASTE-MASKING COMPOSITIONS
#212Compositions and methods for selective GI tract delivery
#213Method of making particles for use in a pharmaceutical composition
#214Compositions and methods for reducing overdose
#215Two-dimensional polymeric structures and method for producing thereof
#216Pharmaceutical composition of rosuvastatin calcium
#217Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers
#218Fortified micronutrient salt formulations
#219Tamper resistant pharmaceutical formulations
#220Matrix and layer compositions for protection of bioactives
#221Pharmaceutical compositions for inhalation
#222Host-guest metal organic framework systems
#223COATED PARTICLES
#224Co-encapsulation of live cells with oxygen-generating particles
#225Drug introducing agent for administration into a living body and manufacturing method
#226Tamper resistant oral opioid agonist formulations
#227Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
#228Use of polyols to obtain stable polymorphous forms of rifaximin
#229Drug delivery product for controlled drug delivery
#230Compositions and methods for reducing overdose
#2315-AMINOLEVULINIC ACID CONJUGATED QUANTUM DOT NANOPARTICLE
#232EXTENDED-RELEASE DOSAGE FORM
#233Nanoparticle-stabilized microcapsules, dispersions comprising nanoparticle-stabilized microcapsules, and method for the treatment of bacterial biofilms
#234Control release of fat soluble antioxidants from an oral formulation and method
#235Method for coating pharmaceutical substrates
#236Multiparticulate Modified Release Composition
#237Devices and methods for therapeutic heat treatment
#238Pharmaceutical Compositions
#239Abuse-resistant drug formulations with built-in overdose protection
#240Oral liquid compositions of guanfacine
#241Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same
#242Multilayered nanoparticle and methods of manufacturing and using the same
#243Method for preparing graphene
#244Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
#245Compositions and methods for obtaining an improved lung function
#246Ingestible, electrical device for oral delivery of a substance
#247Amorphous magnesium-substituted calcium phosphate compositions and their uses
#248Matrix and layer compositions for protection of bioactives
#249EXTENDED RELEASE SUSPENSION COMPOSITIONS
#250FULLY OR PARTIALLY BIODEGRADABLE DEVICE FOR CONTROLLED DRUG DELIVERY
#251Method For The Therapeutic Treatment Of Keratinous Substrate, Mucous Membrane Or Tooth
#2522,4-dinitrophenol formulations and methods using same
#253Mineralizing biosurfactant used for nucleating silica
#254Compositions providing delayed release of actives
#255Delayed Release Cysteamine Bead Formulation, And Methods Of Making And Using Same
#256Composition, method and kit for formation of galvanic cells on the skin
#257HYBRID ALGINATE-SILICA BEADS AND METHOD FOR OBTAINING THEM
#258Oral pharmaceutical formulation
#259Pharmaceutical Compositions Comprising Everolimus
#260Tamper resistant pharmaceutical formulations
#261Solid dosage form of coated bisphosphonate particles
#262HOLLOW NANOPARTICLES WITH HYBRID DOUBLE LAYERS
#263Photo-responsive macro- and micro-liquid marbles
#264Fixed dose combination therapy of Parkinson's disease
#265Pharmaceutical core-shell composite powder and processes for making the same
#266Compostions and methods for enhancing the topical application of an acidic benefit agent
#267Compostions and methods for enhancing the topical application of a basic benefit agent
#268TRANSDERMAL FORMULATION CONTAINING COX INHIBITORS
#269Multicompartmentalized material for the thermostimulated delivery of substances of interest, preparation process and applications
#270Facile method for making non-toxic biomedical compositions comprising hybrid metal-polymer microparticles
#271Fortified micronutrient salt formulations
#272Multicompartmentalized material for the thermostimulated delivery of substances of interest, preparation method thereof and uses of the same
#273Controlled release of biological entities
#274Pharmaceutical compositions for inhalation
#275Method for improving water solubility of slightly soluble substance
#276Silica microcapsules, process of making the same and uses thereof
#277Tamper resistant pharmaceutical formulations
#278Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
#279ORGANIC COMPOUNDS
#280Stable digestive enzyme compositions
#281Mineral-coated microspheres
#282Compositions for the treatment of rosacea
#283Implants for “load bearing” bone substitutions having hierarchical organized architecture deriving from transformation of vegetal structures
#284Taste masked active pharmaceutical powder compositions and processes for making them
#285Formulations of histone deacetylase inhibitor and uses therof
#286Nanoparticles
#287Transdermal formulation containing COX inhibitors
#288Gamma hydroxybutyric acid granules
#289Silica-Coated Calcium Salt Compositions
#290Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
#291Pellet formulation for the treatment of the intestinal tract
#292Microcapsule
#293Polynuclear microcapsules
#294Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
#295Calcium-containing structures and methods of making and using the same
#296COATING OF PARTICLES COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT WITH A CARBONATE SALT OR PHOSPHATE SALT
#297Pellet formulation for the treatment of the intestinal tract
#298Pellet formulation for the treatment of the intestinal tract
#299COATING OF PARTICLES COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT WITH A CARBONATE SALT OR PHOSPHATE SALT
#300Stabilized topical formulations containing core-shell microcapsules